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Purpose. To describe frequency, type, and outcome of re-intervention after endovascular aortic aneurysm repair (EVAR).
Methods. Between September 1996 and December 2003, 308 patients were treated, with data collected prospectively. No
patient was lost to follow up, but two were excluded (one primary conversion, and one post-operative death). Vanguard,
Talent, Excluder, Zenith, and Quantum devices were used. Follow up required a CT scan before discharge. Initially, a CT
scan was done at each follow up. Subsequently, we used duplex ultrasound and abdominal X-ray, with CT scan used
selectively.
Results.Mean follow-up was 36 ^ 22 months. Re-interventions were required in 47 (15%) patients, 31 (66%) elective and
16 (34%) emergency cases. In 32 patients, the primary re-intervention was successful; in 15 patients an additional 13
secondary and four tertiary re-interventions were required. A total of 72 adjunctive manoeuvres were performed: 49
endovascular (68%) and 23 open (32%). The success of endovascular re-interventions was 80%. The success of open re-
interventions was 96%. Open conversions were required in nine patients (3%). There was no mortality.
Conclusion. EVARwas associated with a low burden of re-interventions, with only 15% patients requiring re-intervention.
Our long-term follow up, without regular CT, was simple and effective.
Key Words: Conversion; Endoleak; Migration; Re-intervention; Rupture.
Introduction
Since the introduction of endovascular aneurysm
repair (EVAR) by Parodi in 1991, the technique has
been embraced as a viable alternative to open repair.1
Reported advantages of EVAR are the lower mortality
and morbidity, and the rapid recovery.2,3 The EURO-
STAR registry reported a 30-day mortality of 2.5% in a
series of 4392 patients.4 EVAR, however, is associated
with late complications such as migration of the
prosthesis, endoleaks, endograft occlusion, and even
rupture.5 – 15 Re-interventions to preserve the function
of the endograft are reported in 10–34% of cases.5,8,12,
14 – 19 However, the frequency of re-intervention after
EVAR, the burden of single and multiple procedures
for the individual patient and the overall outcome of
these re-interventions all require further investigation.
The purpose of this study was to describe the long-
term results of EVAR in a consecutive cohort of
patients treated in a single academic institution, and
to report the frequency, type, and outcome of re-
interventions.
Material and Methods
Patients
This is a prospective cohort study of 308 consecutive
elective patients treated with EVAR between Septem-
ber 1996 and December 2003 at a tertiary academic
vascular centre by a single endovascular team. Surgery
was indicated for aneurysms greater than 5 cm in
diameter. An aortic aneurysm greater than 4 cm was
also an indication for surgery if it was saccular or if it
was associated with iliac artery aneurysms greater
than 3.5 cm.
Type of endoprosthesis
Five different types of stent-grafts were used during
the primary procedure (Table 1). In the first 32 patients,
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we used the only available device, Vanguard. When
other products were commercially approved, we used
them according to a strategy that gave preference to
the Talent for large infrarenal necks (.28 mm), the
Zenith for short necks (,20 mm), and the Excluder for
straight long necks but angulated or small iliac vessels.
The most recent device, Quantum, only has been used
in 12 patients. A bifurcated stent-graft design was
used in 298 patients (96.8%), a tube graft in five
patients (1.6%), and an aorto-uniiliac graft in five
patients (1.6%).
Follow up
From September 1996 to January 1999, physical
examination, duplex ultrasound scanning (DUS), and
computed tomography angiography (CTA) or mag-
netic resonance angiography (MRA) were performed
at discharge, at 1, and at 3 months after the interven-
tion; every 6 months for the first 2 years, and yearly
thereafter. From February 1999 to March 2004 with
increasing experience, and as suggested by other
authors, the protocol was changed: following an initial
CT scan before discharge, patients were followed at 1,
6 and 12 months with physical examination, DUS and
a four plane abdominal X-ray.20,21 CTA or MRA was
used only if there was an increase in size of the
aneurysmal sac or the suspicion of an endoleak on
DUS, or if there was evidence of migration or of
compromise of the structural integrity of the stent-
graft on the abdominal X-ray.
Definitions
In the context of this study, complications refer only to
those related to the aneurysm and the stent-graft.
An endoleak was defined as perigraft blood flow
due to an inadequate seal and arising from the
proximal or distal attachments of the endograft,22
from retrograde visceral or lumbar vessels,22 or from
disconnection of modular endografts (type III).23,24
Re-intervention was defined as an endovascular or
open surgical intervention performed after the initial
EVAR in order to maintain the function or patency of
the endograft. When more than one re-intervention
was necessary during follow-up, the classification of
primary, secondary, and tertiary re-intervention was
used.
Patient re-interventions/follow up: after EVAR,
patients may require multiple procedures during one
re-intervention and multiple re-interventions over
time. As a measure of the overall impact of EVAR on
patients treated with this approach, we introduced the
definition of patient re-interventions/follow up. This
refers to the number of re-interventions in separate
surgical treatments, divided by the total number of
patients entering the follow up.
Clinical success of a re-intervention was defined as
follows. If a proximal aortic cuff was used, success was
defined as disappearance of a type I endoleak, no
further downward migration of the prosthesis and no
further aneurysmal growth. If a distal extension or a
recanalisation of an occluded limb or a bridging stent-
graft was used, clinical success was defined as a patent
limb without type I or type III endoleak. If embolisa-
tion or ligation of side branches was used, clinical
success was defined as an aneurysm without type II
endoleak or further expansion. Clinical success of
cross-over bypasses was defined by a patent graft and
successful revascularisation of the ischaemic limb.
Clinical success of open conversions was defined as
patient survival.
An open conversion was defined as a laparotomy
with the removal of the endograft and insertion of a
bifurcated prosthesis. The term laparotomy implied
non-conversion laparotomies only.
Statistics
Summary data for continuous variables are expressed
as mean ^ standard deviation. Data were prospec-
tively collected in an Access database (Microsoft
Corporation). Primary outcomes were clinical success,
graft patency, and patient survival. Time-to-event
variables were studied with Kaplan–Meier survival
analysis and comparison of time-to-event curves
conducted with Peto log-rank test, using SPSS 11.0
(SPSS, Chicago, IL, USA). A P value less than 0.05 was
considered statistically significant.
Table 1. Type of endoprosthesis used
Primary intervention N (%) Re-intervention N (%)
Excluder† 56 (18) 2 (4)
Quantum‡ 12 (4) –
Talent†† 52 (17) 6 (12)
Vanguard* 68 (22) 32 (47)
Zenith** 120 (39) 7 (6)
Total patients 308 47
†Excludere (W.L. Gore, Flagstaff, AZ, USA).
‡Quantume (Cordis, Johnson and Johnson, Fort Lauderdale, FL,
USA).
††Talente (World Medical/Medtronic Corp., Sunrise, FL, USA).
*Vanguarde (Boston Scientific Corp., Waterston, MA, USA).
**Zenithe (Cook, Bloomington, IN, USA).
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Results
In 308 patients undergoing EVAR, the mean age was
70 ^ 11 years and 94% were males. The mean diameter
of the aneurysm was 59 ^ 9 mm (range 40–100 mm).
Preoperative risk factors for the patients are shown in
Table 2. One patient required conversion to open
repair because of technical reasons, and one died of a
myocardial infarction the day after surgery (hospital
mortality, 0.3%) leaving a group of 306 patients for
analysis of long-term results, of whom none was lost to
follow up.
Patients were followed for a mean of 36 ^ 22
months. A total of 126 late complications occurred in
102 patients (33%) (Table 3). However, re-interventions
only were performed in 47 patients (15%). There was
no difference in demographic and risk factors between
patients who did and did not develop complications
after EVAR. Details of the primary re-interventions in
the 47 patients are shown in Table 4. Re-interventions
were performed electively in 31 patients (66%), and on
an emergency basis in 16 (34%). In the latter group,
surgery was required for either acute limb ischaemia
in 14 patients (88%) (nine treated with thrombolysis
followed by additional stenting, and five with a cross-
over bypass) or acute aneurysm (stent-graft discon-
nection with type III endoleak in two patients). One of
these aneurysms was ruptured and treated with open
repair, and the other was an impending rupture and
treated with a bridging stent-graft.
After re-interventions, patients returned to the
regular follow-up programme. No further problems
during follow-up occurred in 32 patients (68%) (i.e. the
primary re-intervention was successful). However, in
15 patients, new complications and adverse events
occurred. In two patients re-intervention was not
necessary: one because a failed embolisation of the
inferior mesenteric artery was not associated with an
endoleak on subsequent CT-scan, and the second
because the occlusion of a limb of the graft resulted in
only mild claudication. The remaining 13 patients
required secondary re-interventions (12 single, and
one multiple simultaneous procedures), and four
patients also required tertiary re-interventions (three
single, and one multiple simultaneous procedures).
Details of these events are summarised in Table 5.
Overall a total of 64 re-interventions were performed
in 47 patients for a patient-interventions/follow up of
21% (64/306).
Since multiple procedures may be performed
during the same surgical session, Table 6 summarises
the results in terms of clinical success for the 72
adjunctive manoeuvres performed in 47 patients. The
overall clinical success of endovascular re-interven-
tions was 80%. Distal extension stent-grafts were not
successful in four of 19 procedures: two occluded and
two disconnected. One occluded stent-graft was not
treated because, as stated above, it only caused mild
claudication; the other resulted in a conversion. The
two disconnections led to a conversion, one directly,
the second after a bridging stent-graft which occluded
8 months later. Four out of the nine recanalisations
with thrombolysis were not successful: in one instance
because the limb of the graft could not be reopened, in
two because the limb of the stent-graft re-occluded
(one at 3 and the other at 30 days), and in one because
of a kink in the graft. The first three patients were
treated with a cross-over bypass and the last with
insertion of a Wallstent.
The clinical success of open re-interventions was
96%. All cross-over grafts remained patent. In five
patients with a type II endoleak, a laparotomy was
performed because the aneurysm diameter had
increased. After opening the aneurysmal sac, the
lumbar arteries were ligated with sutures and the sac
wrapped around the stent-graft. During follow-up,
however, in one of these patients a disconnection
between the body of the endoprosthesis and one of the
limbs occurred and required additional open treat-
ment (laparotomy, ligation of the contra-lateral limb
and cross-over bypass). The mean hospital stay of the
remaining four patients was 12 days (range, 10–17).
Nine patients (3%) underwent open conversion: one
because of a ruptured aneurysm, three because the
complexity of the problem made endovascular treat-
ment untenable and five after failure or complications
associated with previous endovascular re-intervention
(Table 7). Laparotomy was performed with a midline
incision and infra-renal clamping was used in seven
patients, and temporary suprarenal clamping in two.
All nine patients survived and were discharged after a
mean of 11 days (range, 10–11).
The cumulative intervention-free survival for the
Table 2. Pre-operative SVS-ISCVS risk score in patients treated
with EVAR ðN 5 308Þ30
SVS-ISCVS risk score†
0 1 2 3
Co-morbidities (%)
Diabetes 92 3 4 1
Tobacco use 44 27 24 5
Hypertension 46 33 17 4
Hyperlipidemia 54 27 6 14
Cardiac status 47 26 22 5
Carotid disease 94 3 3 1
Renal disease 87 11 1 1
Pulmonary status 68 17 12 3
†Society of Vascular Surgery—International Society of Cardiovas-
cular Surgery, North American Chapter.
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different types of stent-graft used is shown in Fig. 1.
The only statistically significant difference was found
between the Vanguard device and all other types of
stent-grafts ðP , 0:05Þ:
None of the 47 patients died after the secondary
procedure. Five of them (11%) died of causes not
related to the secondary procedure after a mean of 35
months (range 29–48).
Discussion
This cohort study shows that, in appropriately selected
patients, EVAR using predominantly bifurcated pros-
theses has an excellent peri-operative success rate with
low surgical mortality and conversion (each 0.3%). At
36-month follow up, 261 patients (85%) had their
aneurysm successfully excluded by EVAR, without
need for further intervention. Re-interventions2 were
required in 47 patients (15%), with no mortality. In
patients requiring re-intervention, endovascular rescue
procedures were possible in 68% with a success rate of
80%; and open re-intervention was necessary in 32%
with a clinical success rate of 96%. Overall 285 of 306
(93%) patients had their aneurysm treated with endo-
vascular procedures alone, and 297 (97%) with a
combination of endovascular and open surgery (cross-
over bypass or laparotomy for closure of endoleaks).
Conversion to open aneurysm repair was required in
only 3% of the entire cohort of patients. Complications,
which did not require interventions, but needed careful
surveillance developed in an additional 18% of patients.
The concept of patient-interventions/follow up
helps to clarify the overall impact of multiple
procedures for patients undergoing EVAR. The service
impact of repeated procedures is similar if many
patients receive one re-intervention or only a few
patients receive multiple re-interventions in different
sessions. In our series, EVAR was associated with a
low patient-interventions/follow up (21%). This also
was an expression of the effectiveness of re-interven-
tions after EVAR.
The majority of the elective re-interventions were
required because of a persistent endoleak, graft
migration, or failure of the aneurysmal sac to reduce
in size. The majority of emergency re-interventions
(88%) were required for acute leg ischaemia. Only two
patients were treated acutely for reasons other than
limb occlusion, both because of a prosthetic limb
disconnection. The first presented with a ruptured and
the second with a symptomatic aneurysm, at 44 and 21
months, respectively, after the primary repair. The first
patient underwent open conversion, and the second
received a bridging stent-graft, both successful. Retro-
spectively, it was clear that the abdominal X-ray of the
patient with symptomatic aneurysm had shown an
initial migration of the contra-lateral limb. At this
stage a bridging stent-graft could have been easily
inserted preventing the complete dislocation, which
required a more complex procedure. This further
illustrates the importance of regular and meticulous
follow-up after EVAR.
In our experience endovascular re-interventions for
problems related to the proximal end of the prosthesis
(cuff extensions) were invariably successful, while
distal extensions and recanalisation of occluded limbs
failed in 21 and 44% of cases, respectively. We believe
that the current success of proximal cuff extensions is
related to the position of the cuffs very close to the
orifices of the renal arteries and to the use of cuffs with
suprarenal fixation with hooks and barbs. The rela-
tively high failure rate of distal extensions and
Table 3. Patients with delayed complications and re-interventions
after EVAR
Patients N (%)
Patients with complications non
requiring re-interventions
55 (18)
Number of complications 57
Type of complication
Migration 25
Kink 5
Type II endoleak† 26
Limb occlusion 1
Patients with complications requiring
re-interventions
47 (15)
Number of complications 69
Patients without complications 204 (67)
Total patients 306
Total complications 126
†Disappearing within 6 months or without growth of the aneurysm.
Table 4. Re-interventions performed in 47 patients
N
Single procedure 41
Aortic cuff 5
Extensions† 13
Bridging stent-graft 2
Recanalisation 9
Aortic Palmaz stent 1
Embolisation of IMA 1
Cross over bypass 5
Laparotomy 1
Open conversion 4
Multiple procedures in one session 6
Proximal cuff þ extension 3
Extension þ embolisation of IMA 1
Bridging stent-graft þ embolisation of IMA 1
Bridging stent-graft þ extension 1
†In this group are included patients who received 4 wallstents; IMA:
inferior mesenteric artery.
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recanalisations is secondary to the increased burden of
graft material in a narrow lumen environment, and
perhaps to the progression of pathology (dilatation,
kinking, and calcification) in the native arteries.
The Vanguard device was associated with the most
complications. However, 80% of all complications also
occurred in the first 100 stent-grafts, suggesting that
the learning curve might have played a role in the high
incidence of complications observed with the Van-
guard device. The learning curve for EVAR depends
on measurement issues, choice of size of prostheses
and different physical characteristics of the grafts.
Even with the increased availability of different
devices, we do share the opinion that the ideal graft
is yet available and continue to tailor the choice of
graft based on the aorto-iliac anatomy and the physical
characteristics of the stent-graft currently available.
Early in our cohort we used the Talent device for large
infrarenal necks (.28 mm), since it was the only
suitable device. Currently, for large (.28 mm) or short
necks (,20 mm) we prefer to use the Zenith device
because of its strong suprarenal fixation, and the
Excluder device for straight long necks but angulated
or small iliac vessels. Even in these hostile iliac arteries
we have not observed limb occlusion with an Excluder
endograft.
In agreement with other authors, our strategy for
management of type II endoleaks is conservative if the
aneurysm is shrinking or remains stable.8,25,26 Lapar-
otomy is performed for an increase in aneurysm size.
The aneurysmal sac is opened, the lumbar arteries or
the inferior mesenteric artery are suture ligated and
the sac wrapped around the endograft. We do not
remove the prosthesis at this time since this is a
complex, unwarranted procedure. Other treatment
options include thrombin or glue injection, coil
embolisation, and laparoscopic clipping.8,12,16,22,27 We
have not used any of these adjunct treatments.
The importance of follow-up is underscored by the
late acute complications, which may develop after
EVAR. Aortic rupture after insertion of endoprosthesis
is one dramatic example. This in the EUROSTAR
report has been estimated to occur with a frequency of
1% per year. Recognised risk factors for rupture are
graft migration, type I and type III endoleaks.28
However, in our experience, perhaps because of
early detection and treatment of complications,
EVAR was associated with a rupture rate of only
0.3%. Our initial follow-up protocol required a CT scan
at discharge, 1, 3, 6, 12, 18 and 24 months, and yearly
thereafter. This was too onerous both for patients and
physicians. With data emerging from the EUROSTAR
registry suggesting that CT scan imaging could be
reduced to annually, and other authors reporting on
the role of abdominal X-ray and DUS in the follow up
Table 5. Details of patients with complications and with newly arisen problems after initial secondary intervention
Patient (no.) Primary re-intervention Complication Secondary re-intervention Complication Tertiary re-intervention
1 Aortic cuff Endoleak type II Laparotomy – –
2 Aortic cuff Endoleak type II Laparotomy Disconnection Laparotomy
3 Aortic cuff þ extension Limb Occlusion Conversion – –
4 Extension Limb Occlusion – – –
5 Extension Endoleak type II Laparotomy – –
6 Extension Migration (P þ D) Cuff þ extension Disconnection Conversion
7 Extension Disconnection Bridging stent-graft Limb Occlusion Conversion
8 Bridging Limb occlusion† Cross over bypass – –
9 Recanalisation Migration/kink (D) Wallstent – –
10 Recanalisation Limb occlusion Cross over bypass – –
11 Recanalisation Limb occlusion Cross over bypass – –
12 Recanalisation Limb occlusion Cross over bypass Migration (P) Cuff þ Wallstent
13 Embolisation Technical failure – – –
14 Cross over bypass Migration (P) Conversion – –
15 Cross over bypass Migration (P) Conversion – –
P, proximal; D, distal.
†Contra-lateral side.
Table 6. Clinical outcome of all secondary procedures performed
in 47 patients
Re-interventions N (%) Clinical success N (%)
Endovascular 49 (68) 39 (80)
Aortic cuff 10 10 (100)
Extension 19 15 (79)
Recanalisation 9 5 (56)
Bridging stent-graft 5 4 (80)
Embolisation 3 2 (66)
Palmaz stent 1 1 (100)
Wallstent 2 2 (100)
Open surgical 23 (32) 22 (96)
Cross-over bypass 9 9 (100)
Laparotomy 5 4 (80)
Open conversion 9 9 (100)
Total 72 61 (85)
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of EVAR, we felt appropriate to change our strategy.20,
29 We included only a CT scan before discharge, and at
6 and 12-month follow-ups, and thereafter yearly
examination using abdominal X-ray and DUS, per-
formed and interpreted by experienced vascular
technicians and physicians. Parameters studied at
each interim follow-up are the diameter of the
aneurysm and the proximal neck, the presence or
absence of endoleaks, and the position and integrity of
the stent-graft. If any of these parameters are abnor-
mal, a CT scan or an MRA are performed. Problems
identified with these imaging techniques may trigger
Table 7. Details of open conversions
Patient
(no.)
Stent-graft
(type)
Time since EVAR
(months)
Previous re-interventions Indication for conversion Urgent treatment Outcome
(at 30 days)
1 Vanguard 54 Cuff þ extension Limb Occlusion No Survived
2 Vanguard 57 Extension; cuff þ extension Disconnection No Survived
3 Vanguard 64 Extension; bridging Limb Occlusion No Survived
4 Vanguard 44 No Migration (P þ D) No Survived
5 Talent 27 No Migration; Limb Occlusion No Survived
6 Vanguard 44 No Migration; Limb Occlusion No Survived
7 Vanguard 45 No Rupture Yes Survived
8 Vanguard 41 Cross over bypass Migration (P) No Survived
9 Vanguard 24 Cross over bypass Migration (P) No Survived
P, proximal; D, distal.
Fig. 1. Cumulative intervention free survival rates.
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an intervention or, if the problem does not appear to be
life or limb threatening, a further follow up at 6
months. The lack of temporal trends in the frequency
and type of acute complications requiring surgery and
the low incidence of aortic rupture after insertion of
endoprosthesis are a pragmatic proof of the effective-
ness of our follow-up strategy.
Bias is inherent to cohort studies of this type, and
future development in graft technology may alter the
natural history of endoprosthesis. However, strengths
of our study include the prospective design, the large
number of patients included, the fact that no patients
were lost to follow up, the consistency of events over
time, the finding that, with the exception of the
Vanguard device, no difference in re-intervention-
free survival was identified among different types of
devices, and the similarity of results with those
identified by other authors (Table 8). For these reasons
we feel that our results are realistic and are gener-
alisable to similar tertiary centres taking care of
patients with infra-renal aortic aneurysms.
The implication of this work for clinical practice is
that a strategy of using bifurcated endoprosthesis in
selected patients is effective for the management of
infra-renal aortic aneurysms, when the appropriate
learning curve has been accomplished and when the
type of graft is individualised to the particular aorto-
iliac anatomy. Endovascular re-interventions should
be preferred where possible, particularly for proximal
extension cuffs, which are usually associated with a
high success rate. In the management of graft limb
complications, thrombolysis and distal endograft
extensions also are effective, but a higher failure rate
should be anticipated. Finally, our type of follow-up is
simple, practically feasible, and it was not associated
with increased mortality and morbidity.
In addition to a meticulous description of the
indications, techniques, and strategy of follow up, we
suggest that future studies of re-interventions after
EVAR include in their results the patient-re-interven-
tions/follow-up as an expression of the burden of
multiple interventions on patients undergoing this
strategy of management of infrarenal aortic aneurysm.
Conclusions
Our findings, derived from a large prospective cohort
of patients treated by a single endovascular team at a
tertiary vascular centre, confirm that with appropriate
surveillance and re-intervention, EVAR can spare an
open aneurysm repair in 97% of individuals with
suitable aortic anatomy. The burden of repeated
procedures to patients (15%) was relatively low. OurTa
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simplified follow-up was effective and an integral part
of management of aneurysms treated with EVAR, in
order to avoid life or limb threatening complications.
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